Pei Dong

651 Dongfeng East Road
Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 114 publications

Prognostic impact of lymphovascular invasion and efficacy of adjuvant therapy in patients with non-metastatic clear cell renal cell carcinoma: a single-center retrospective cohort study

Prognostic impact of lymphovascular invasion and efficacy of adjuvant therapy in patients with non-metastatic clear cell renal cell carcinoma: a single-center retrospective cohort study

Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]

Published: May 27, 2026

Corrigendum to "Response evaluation and tumor shrinkage pattern post-SBRT for renal cell carcinoma" [Radiother. Oncol. 206 (2025) 110802].

Corrigendum to "Response evaluation and tumor shrinkage pattern post-SBRT for renal cell carcinoma" [Radiother. Oncol. 206 (2025) 110802].

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: April 09, 2026

Prognostic value of lymph node dissection in radical nephrectomy for cN0M0 renal cell carcinoma

Prognostic value of lymph node dissection in radical nephrectomy for cN0M0 renal cell carcinoma

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: February 13, 2026

Tubeless Retroperitoneal Robot-assisted Partial Nephrectomy: An Innovative Approach to Treat Early Renal Tumor.

Tubeless Retroperitoneal Robot-assisted Partial Nephrectomy: An Innovative Approach to Treat Early Renal Tumor.

Journal: International braz j urol : official journal of the Brazilian Society of Urology

Published: January 19, 2026

Correction: Selective Artery Clamping Superior to Main Artery Clamping in Preserving Ipsilateral Renal Function after Minimally Invasive Partial Nephrectomy under Prolonged Warm Ischemia.

Correction: Selective Artery Clamping Superior to Main Artery Clamping in Preserving Ipsilateral Renal Function after Minimally Invasive Partial Nephrectomy under Prolonged Warm Ischemia.

Journal: Annals of surgical oncology

Published: January 16, 2026

Impact of hepatotoxicity and lipid metabolism-related toxicity on survival and quality of life in patients with high-volume metastatic hormone-sensitive prostate cancer treated with rezvilutamide in the CHART trial: a post hoc analysis.

Impact of hepatotoxicity and lipid metabolism-related toxicity on survival and quality of life in patients with high-volume metastatic hormone-sensitive prostate cancer treated with rezvilutamide in the CHART trial: a post hoc analysis.

Journal: BMC medicine

Published: December 09, 2025

Camrelizumab plus apatinib for immune checkpoint inhibitor-naive patients with metastatic clear cell renal cell carcinoma after first-line tyrosine kinase inhibitor treatment failure: a single-arm phase 2 trial.

Camrelizumab plus apatinib for immune checkpoint inhibitor-naive patients with metastatic clear cell renal cell carcinoma after first-line tyrosine kinase inhibitor treatment failure: a single-arm phase 2 trial.

Journal: BMC medicine

Published: November 21, 2025

Selective Artery Clamping Superior to Main Artery Clamping in Preserving Ipsilateral Renal Function after Minimally Invasive Partial Nephrectomy under Prolonged Warm Ischemia.

Selective Artery Clamping Superior to Main Artery Clamping in Preserving Ipsilateral Renal Function after Minimally Invasive Partial Nephrectomy under Prolonged Warm Ischemia.

Journal: Annals of surgical oncology

Published: October 23, 2025

Functional and volumetric changes following partial nephrectomy for large (≥ 7 cm) renal masses: a comparative study.

Functional and volumetric changes following partial nephrectomy for large (≥ 7 cm) renal masses: a comparative study.

Journal: World journal of urology

Published: October 12, 2025

CRISPR Screening Reveals SAA1-Driven Neutrophil Extracellular Traps Promote CD8⁺ T Cell Dysfunction in Renal Cell Carcinoma.

CRISPR Screening Reveals SAA1-Driven Neutrophil Extracellular Traps Promote CD8⁺ T Cell Dysfunction in Renal Cell Carcinoma.

Journal: Cancer research

Published: October 07, 2025

Stereotactic body radiotherapy plus sunitinib vs. sunitinib alone in treatment-naive oligometastatic renal cell carcinoma: A phase 2 clinical trial.

Stereotactic body radiotherapy plus sunitinib vs. sunitinib alone in treatment-naive oligometastatic renal cell carcinoma: A phase 2 clinical trial.

Journal: Cell reports. Medicine

Published: September 24, 2025

Minimally Invasive Partial versus Radical Nephrectomy for Non-metastatic pT3a Renal Cell Carcinoma: a Multicenter Matched Cohort Study.

Minimally Invasive Partial versus Radical Nephrectomy for Non-metastatic pT3a Renal Cell Carcinoma: a Multicenter Matched Cohort Study.

Journal: International braz j urol : official journal of the Brazilian Society of Urology

Published: September 09, 2025

Showing 1-12 of 114

Last Updated: 09/26/2026